Delivery Order SPE2DB22D3501-SPE2DB25FTE49

Award Date 10/17/24
Potential Completion Date 10/18/24
Potential Value $4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,290.24 firm fixed price delivery order covers the supply of RENFLEXIS 100 MG VIALS, a pharmaceutical product. The contract has an ultimate completion date of January 21, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,941.94 firm fixed-price delivery order is for the supply of RENFLEXIS 100 MG VIALS, a pharmaceutical product. The award has an ultimate completion date of November 8, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,339.47 firm fixed-price delivery order is for the supply of RENFLEXIS 100 MG VIALS medical products. The contract has an ultimate completion date of November 22, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of RENFLEXIS 100 MG VIALS to the U.S. Defense Logistics Agency (DLA). The $20,582.44 Firm Fixed Price delivery order contract has an ultimate completion date of August 7, 2024. AmerisourceBergen holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical and the Department of Justice Federal Bureau of Investigation, valued at up to $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,371.30 firm fixed-price delivery order is for RENFLEXIS 100 MG VIALS, a medical product, with a period of performance through February 11, 2025. The award is not designated under any set-aside program. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award is a delivery order with the Defense Logistics Agency (DLA) valued at $4,716.99 for the supply of RENFLEXIS 100 MG VIALS by AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a firm fixed price and is set to be completed by January 24, 2023. AmerisourceBergen maintains a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,970.00 firm fixed-price delivery order is for the supply of RENFLEXIS 100 MG VIALS, a pharmaceutical product. The contract has an ultimate completion date of December 6, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of RENFLEXIS 100 MG VIALS. The contract has a ceiling value of $18,878.21 and a completion date of December 17, 2024. It is a delivery order contract with a firm fixed price pricing type. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of RENFLEXIS 100 MG VIALS. The firm-fixed-price delivery order, valued at $5,807.85, has an ultimate completion date of December 15, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award is a delivery order valued at $6,187.34 placed by the Defense Logistics Agency (DLA) with AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of RENFLEXIS 100 MG VIALS, a pharmaceutical product, to support military healthcare programs. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB25FTE49
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of RENFLEXIS 100 mg vials. The contract has a ceiling value of $3,982.80 and is a Firm Fixed Price Delivery Order, with an ultimate completion date of October 18, 2024. This award is not associated with a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 1/16/25, 9:25 AM